Pharmacy & Medication Technology Testing
Where a wrong drug or a missed interaction is never just a software bug.
Pharmacy and medication technology platforms carry one of the highest clinical-risk profiles in health tech. E-prescribing errors, drug-interaction logic failures, and dispensing-workflow gaps aren’t just software defects — they’re patient-safety incidents. We test the full medication-management stack with the clinical domain knowledge your generic QA firm doesn’t carry.
E-prescribing drug-interaction rules, contraindication logic, and allergy-flag verification tested against clinical formulary standards.
Patient medication records, prescription histories, and pharmacy data protected across every access point and integration boundary.
HIPAA, FDA, DEA, NHS, and state pharmacy-board requirements mapped to test evidence from day one.
HL7, FHIR, and proprietary pharmacy-system integrations tested across expected and edge-case data-exchange scenarios.
What goes wrong when pharmacy and medication platforms skip clinical QA.
Medication technology sits at the intersection of clinical accuracy, regulatory compliance, and patient safety. A drug-interaction rule that fires incorrectly, a formulary lookup that returns the wrong result, or a dispensing workflow that drops a clinical alert isn’t a UX issue — it’s a harm event.
E-prescribing platforms rely on interaction logic that is rarely tested under real clinical load with real drug combinations. A rule that works in a demo environment fails silently in production when two legitimate prescriptions create a dangerous interaction no one flagged.
Formulary data changes constantly. A platform that returns an incorrect formulary status, a deprecated drug, or a wrong tier classification causes prescribers to make decisions based on bad data — with downstream clinical and financial consequences.
Medication alerts, clinical warnings, and pharmacist-review flags that are generated correctly but lost in workflow handoffs are invisible in functional testing. They only surface when a pharmacist or prescriber reports that they never saw an alert they should have.
Controlled-substance prescribing and dispensing requires complete, tamper-evident audit trails. Gaps in logging, missing event records, and incomplete chain-of-custody documentation are discovered at audit time — not in standard QA cycles.
Prescription data, medication histories, and patient identifiers flow across EHR integrations, pharmacy benefit managers, and third-party fulfillment platforms. One misconfigured data exchange is a HIPAA-reportable breach.
Pharmacy regulations vary by US state and differ significantly between US and UK markets. A platform that is compliant in one jurisdiction frequently has untested gaps in another — discovered during expansion, not before.
We already know how drug-interaction logic should behave, what a correct formulary response looks like, and what a dispensing-workflow alert chain should produce — before we write a single test case.
Every drug-interaction rule, contraindication flag, allergy alert, and therapeutic-duplication warning is tested against clinical formulary standards and real-world prescribing scenarios — not just checked for existence.
Complete chain-of-custody logging, controlled-substance prescribing audit trails, and DEA Schedule II–V handling tested for completeness, accuracy, and tamper-evidence across every workflow.
Prescription data, medication histories, and patient identifiers never enter our test environments unprotected. Synthetic clinical data is built specifically for your platform’s medication workflows.
HIPAA, DEA, NHS, CQC, and state pharmacy-board requirements tested in parallel — so compliance gaps in secondary markets are found before expansion, not during.
Automated regression suites triggered whenever formulary data, interaction rules, or dispensing logic changes — so an update never silently breaks a clinical safety check.
Nine testing areas across your platform.
Validating drug-drug, drug-allergy, drug-condition, and therapeutic-duplication interaction rules against clinical formulary standards across real prescribing scenarios.
End-to-end prescribing workflow validation including prescriber authentication, drug selection, dosage logic, formulary check, and pharmacy routing across provider types and specialties.
Testing the complete dispensing process from prescription receipt through clinical review, dispensing confirmation, and patient notification — including alert-chain integrity at every handoff.
Verifying patient medication records, prescription histories, and pharmacy data are isolated, encrypted, and protected across every integration boundary and access-control layer.
HIPAA, DEA Schedule II–V, FDA drug labelling, NHS medicines regulation, and state pharmacy-board requirements mapped to test evidence throughout the engagement.
HL7 FHIR, pharmacy benefit manager, and proprietary system integrations tested for data accuracy, message handling, formulary data exchange, and edge-case failure modes.
Validating formulary lookups, tier classifications, prior-authorisation logic, and formulary-update propagation accuracy across prescriber-facing interfaces and pharmacy systems.
Verifying complete, tamper-evident audit trails for controlled-substance prescribing, dispensing, and refill workflows across all DEA Schedule categories.
Automated clinical regression suites covering drug-interaction logic, dispensing workflows, and formulary accuracy on every release — so updates never silently break a clinical safety rule.
Up and running in 4 simple steps.
We learn your platform, medication workflows, pharmacy-system integrations, and clinical compliance obligations in a focused 30-minute session.
We map your full medication-technology stack, identify your highest-risk clinical and regulatory gaps, and build a tailored testing strategy.
Drug-interaction testing, dispensing-workflow validation, regulatory-compliance mapping, and PHI-security testing with severity-rated clinical findings.
Detailed findings report with clinical severity ratings, regulatory traceability, and a prioritised remediation roadmap for your next release cycle.
What clinical software teams say.
“ClinVerify found that our drug-interaction engine was silently dropping allergy alerts when a prescriber had more than twelve active medications loaded. That is exactly the kind of failure that does not show up in a demo and does not show up in standard testing. It shows up when a pharmacist calls asking why they never saw a warning.”
Marcus T.
CTO · E-Prescribing Platform · US
“We were expanding from three US states into a fourth with different controlled-substance reporting requirements. ClinVerify mapped every compliance gap before we went live. We would have discovered those gaps six months later, from a regulator.”
Rachel B.
VP Engineering · Pharmacy Technology Platform · US
“Our SOC 2 Type II audit specifically called out the completeness of our dispensing audit-trail documentation. That came directly from ClinVerify’s testing process — and it was the evidence that closed our first NHS pharmacy trust contract.”
James O.
Head of Product · Medication Management SaaS · UK
Pharmacy & Medication Technology Testing Packages
Choose the level of clinical safety validation your platform stage and regulatory obligations require.
| Feature | Vital Check | PulseGuard | CoreShield | ApexQA Suite |
|---|---|---|---|---|
| Core Testing | ||||
| Functional & UI testing | ✓ | ✓ | ✓ | ✓ |
| API & integration testing | — | ✓ | ✓ | ✓ |
| Performance & load testing | — | Basic | Advanced | Unlimited |
| Test automation framework | — | — | Setup | Full build |
| CI/CD pipeline integration | — | — | — | ✓ |
| Pharmacy Specific | ||||
| Drug interaction logic testing | ✓ | ✓ | ✓ | ✓ |
| E-prescribing workflow testing | ✓ | ✓ | ✓ | ✓ |
| Dispensing workflow testing | — | ✓ | ✓ | ✓ |
| Formulary data integrity testing | — | ✓ | ✓ | ✓ |
| PHI & medication data security | — | — | ✓ | ✓ |
| EHR & pharmacy system integration | — | — | ✓ | ✓ |
| Controlled substance audit testing | — | — | ✓ | ✓ |
| Multi-jurisdiction compliance testing | — | — | — | ✓ |
| Compliance & Monitoring | ||||
| HIPAA compliance testing | — | — | ✓ | ✓ |
| DEA controlled substance compliance | — | — | ✓ | ✓ |
| NHS & UK pharmacy regulation testing | — | — | — | ✓ |
| Regression on formulary updates | — | — | — | ✓ |
| Dedicated clinical QA lead | — | — | ✓ | ✓ |
| 24/7 critical defect SLA | — | — | — | ✓ |
Frequently asked questions.
How do you test drug interaction logic without using real patient data?
We design synthetic prescribing scenarios that reflect real clinical complexity — polypharmacy patients, high-risk drug combinations, allergy profiles, and condition-specific contraindication cases — without using any real patient medication records. Every interaction rule is tested against validated clinical formulary standards using synthetic data built specifically for your platform.
What pharmacy regulatory requirements do you cover?
We cover HIPAA for patient medication data, DEA Schedule II–V requirements for controlled-substance prescribing and dispensing, FDA drug labelling and formulary requirements for US platforms, NHS medicines regulation and CQC requirements for UK platforms, and relevant state pharmacy-board regulations for multi-state US operations. Regulatory traceability documentation is built as we test.
Can you test EHR integrations and pharmacy benefit manager connections?
Yes. We test HL7 FHIR-based EHR integrations, pharmacy benefit manager connections, and proprietary pharmacy-system APIs for data accuracy, message-handling integrity, formulary data-exchange correctness, and edge-case failure modes — including what happens when a downstream system returns an unexpected response or goes offline.
How do you handle controlled substance and DEA audit trail testing?
We verify that every controlled-substance prescribing, dispensing, and refill event produces a complete, accurate, and tamper-evident audit-log entry. We test across all DEA Schedule categories, check for missing or incomplete log records, verify chain-of-custody integrity, and confirm that audit logs are formatted correctly for regulatory submission.
How quickly can you get started?
A free 30-minute discovery call is available within 24 hours. Following that, we typically begin the QA audit and test-planning phase within one week. The speed of the full engagement depends on your platform’s scope, integrations, and regulatory obligations — we confirm a realistic timeline at the end of the discovery call. Email info@clinverify.com or book a scoping call.
Let’s deliver quality together.
Free QA audit. Know your biggest pharmacy-platform risks in 30 minutes.
Get a free QA auditStart with a discovery call.
Tell us about your pharmacy or medication technology platform and we’ll map out exactly what testing you need — no obligation.
Email us
Book a call
Fast response
A free 30-minute discovery call, available within 24 hours.